Home  /  Resource Library  /  Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study

Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study

Study examined the effectiveness of combining chemotherapy with radiation for the first line treatment of extranodal natural killer t-cell lymphoma.